SPRY4 and cancer: Similar results were also found in other types of cancer, and a higher expression of SPRY4-IT1 predicted poor prognosis in many cancers, such as gastric cancer, colorectal cancer, non-small cell lung cancer, and breast cancer [15, 16, 18, 26].